Cargando…

Targeting B-cells Mitigates Autoimmune Diabetes in NOD Mice: What Is Plan B?

Detalles Bibliográficos
Autores principales:	Smith, Susan H., Tedder, Thomas F.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699866/ https://www.ncbi.nlm.nih.gov/pubmed/19564459 http://dx.doi.org/10.2337/db09-0497

Ejemplares similares

Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes: Is It a Solution?
por: Chatenoud, Lucienne
Publicado: (2013)

Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
por: Wang, Xiaojie, et al.
Publicado: (2011)

Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes
por: Boldison, Joanne, et al.
Publicado: (2022)

Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
por: Jhala, Gaurang, et al.
Publicado: (2021)

Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics
por: Kim, Tae Kang, et al.
Publicado: (2020)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
por: Li, Shiri, et al.
Publicado: (2021)

Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice
por: Ramakrishnan, Parameswaran, et al.
Publicado: (2016)

B cells as a therapeutic target in autoimmune disease
por: Goronzy, Jörg J, et al.
Publicado: (2003)

T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
Publicado: (1989)

NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice
por: Beilke, Joshua N., et al.
Publicado: (2012)

Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice
por: Alkan, Manal, et al.
Publicado: (2015)

Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy
por: Wang, Duncheng, et al.
Publicado: (2015)

Effect of Arginase-1 Inhibition on the Incidence of Autoimmune Diabetes in NOD Mice
por: Hernandez, Luis F, et al.
Publicado: (2018)

Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice
por: Salomon, Benoît, et al.
Publicado: (2001)

IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
por: Kalampokis, Ioannis, et al.
Publicado: (2013)

Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
por: Emamaullee, Juliet A., et al.
Publicado: (2009)

The NOD Mouse Beyond Autoimmune Diabetes
por: Aubin, Anne-Marie, et al.
Publicado: (2022)

Nearby Construction Impedes the Progression to Overt Autoimmune Diabetes in NOD Mice
por: Hillhouse, Erin E., et al.
Publicado: (2013)

TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
por: Cao, Hui, et al.
Publicado: (2015)

High‐fat diet prevents the development of autoimmune diabetes in NOD mice
por: Clark, Amy L., et al.
Publicado: (2021)

WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis
por: Ferris, Stephen T., et al.
Publicado: (2023)

Type 1 diabetes: what is the role of autoimmunity in β cell death?
por: Donath, Marc Y.
Publicado: (2022)

Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice
por: Xiao, Ling, et al.
Publicado: (2018)

Toll-like receptor 4 inhibition prevents autoimmune diabetes in NOD mice
por: Alibashe-Ahmed, Mohamed, et al.
Publicado: (2019)

The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
por: Ansari, Mohammed Javeed I., et al.
Publicado: (2003)

The Role of Lymphocyte Subsets in Accelerated Diabetes in Nonobese Diabetic–Rat Insulin Promoter–B7-1 (NOD-RIP-B7-1) Mice
por: Susan Wong, F., et al.
Publicado: (1998)

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
Publicado: (1996)

The effect of spermidine on autoimmunity and beta cell function in NOD mice
por: Karacay, Ceren, et al.
Publicado: (2022)

The Dual Role of Scavenger Receptor Class A in Development of Diabetes in Autoimmune NOD Mice
por: Shimizu, Mami, et al.
Publicado: (2014)

Impact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice
por: Kim, Donghee, et al.
Publicado: (2017)

Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes
Publicado: (1992)

Amplified B Lymphocyte CD40 Signaling Drives Regulatory B10 Cell Expansion in Mice
por: Poe, Jonathan C., et al.
Publicado: (2011)

GABA(B)-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice
por: Tian, Jide, et al.
Publicado: (2021)

Formation of Autoimmune Lesions Is Independent of Antibiotic Treatment in NOD Mice
por: Sato, Mami, et al.
Publicado: (2021)

Involvement of age-associated B cells in EBV-triggered autoimmunity
por: Sachinidis, Athanasios, et al.
Publicado: (2022)

Prevention of Autoimmune Diabetes and Induction of β-Cell Proliferation in NOD Mice by Hyperbaric Oxygen Therapy
por: Faleo, Gaetano, et al.
Publicado: (2012)

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice
Publicado: (1996)

The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
por: Borg, Danielle J., et al.
Publicado: (2017)

Targeting fibrocytes in autoimmunity
por: Bucala, Richard J.
Publicado: (2022)

Molecular pathway alterations in CD4 T-cells of nonobese diabetic (NOD) mice in the preinsulitis phase of autoimmune diabetes
por: Kakoola, Dorothy N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pb69cvurspf5p9oagmn2h71g1b